Clinical trials are a vital key to finding new treatments and drugs for a plethora of diseases and illnesses. 7-7-Julie-Vose1But sometimes, the term can be considered a negative connotation associated with lab rats, placebos and more uncomplimentary terms.

Recently, oncologist Julie Vose, MD, MBA, FASCO, submitted a letter to the editor which appeared in the June 25 New York Times.

In the letter, Dr. Vose was responding to an earlier New York Times editorial singing the praises of clinical trials, as written by Stan Collender, a current cancer patient and participant in a clinical trial.

Dr. Vose currently serves as president of the American Society of Clinical Oncology and is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center – UNMC and the Associate Director of Clinical Research at the Fred & Pamela Buffett Cancer Center.